| Literature DB >> 30770245 |
Hitesh Arora1, Sara Morgan Wilcox2, Laura Alexandra Johnson3, Lonna Munro4, Brett Alexander Eyford5, Cheryl Gurine Pfeifer4, Ian Welch6, Wilfred Arthur Jefferies7.
Abstract
Sepsis is a bi-phasic inflammatory disease that threatens approximately 30 million lives and claims over 14 million annually, yet little is known regarding the molecular switches and pathways that regulate this disease. Here, we have described ABCF1, an ATP-Binding Cassette (ABC) family member protein, which possesses an E2 ubiquitin enzyme activity, through which it controls the Lipopolysaccharide (LPS)- Toll-like Receptor-4 (TLR4) mediated gram-negative insult by targeting key proteins for K63-polyubiquitination. Ubiquitination by ABCF1 shifts the inflammatory profile from an early phase MyD88-dependent to a late phase TRIF-dependent signaling pathway, thereby regulating TLR4 endocytosis and modulating macrophage polarization from M1 to M2 phase. Physiologically, ABCF1 regulates the shift from the inflammatory phase of sepsis to the endotoxin tolerance phase, and modulates cytokine storm and interferon-β (IFN-β)-dependent production by the immunotherapeutic mediator, SIRT1. Consequently, ABCF1 controls sepsis induced mortality by repressing hypotension-induced renal circulatory dysfunction.Entities:
Keywords: ABCF1; E2 ubiquitin-conjugating enzyme; SIRT1; TLR4 endocytosis; TRIF-signaling; endotoxin tolerance; hypotension; macrophage polarization; renal circulatory failure; sepsis
Mesh:
Substances:
Year: 2019 PMID: 30770245 DOI: 10.1016/j.immuni.2019.01.014
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745